U.S. Other Utilities Stock News

Terreno Realty Corporation recently announced the completion and full leasing of new LEED-certified industrial distribution buildings at Countyline Corporate Park Phase IV in Hialeah, Florida, along with an early 63,000-square-foot lease renewal in Seattle with a co-warehousing provider. These developments highlight Terreno Realty’s progress in expanding its logistics footprint and underscore robust ongoing tenant demand in key U.S. markets. We'll explore how the stabilization and full...

If you have been following Palantir Technologies (PLTR), you know the company's story is evolving beyond its government roots and into a much wider commercial footprint. This year, a series of new partnerships is propelling Palantir's reputation as a go-to provider of AI-powered software, with major expansions announced alongside Lear Corporation, Lumen Technologies, and The Nuclear Company. Each collaboration not only opens new markets, but also shows how clients are relying on Palantir's...

If you are considering what to do with Hormel Foods (HRL) shares right now, you are not alone. The company just reported earnings and, while sales ticked up modestly, management flagged surging commodity costs, especially for pork and beef, as a real pain point for margins. In response, Hormel’s leadership revised their full-year profit expectations downward. This reflects the squeeze from these input costs and management cautioned investors that it could take time before profit margins...

ON Semiconductor (ON) just found itself at the center of the headlines, thanks to President Donald Trump’s announcement of substantial new tariffs on imported semiconductors. The twist is that companies with U.S.-based manufacturing or plans to invest domestically are exempt. This carve-out brings ON Semiconductor’s operational model sharply into focus. For investors, this is more than just a policy update as it raises immediate questions about ON’s cost structure and future pricing power if...

Readers hoping to buy Nordson Corporation ( NASDAQ:NDSN ) for its dividend will need to make their move shortly, as the...

Dover's MAAG Group recently introduced the PEARLO Compact System, an underwater pelletizing solution targeted at small-scale plastics manufacturing, featuring a compact design, efficient cleaning, and low waste, with throughput capacities of 50 to 500 kilograms per hour. The launch, highlighted for debut at the K 2025 trade show in Düsseldorf, signals Dover's ongoing commitment to product innovation and its ambition to grow within the plastics and rubber sector. We'll explore how the...

If you have been following SkyWest (SKYW), you might have noticed a new wave of optimism swirling around the stock. Several analysts recently raised their earnings estimates for the year ahead and re-affirmed strong buy ratings, painting a picture of rising confidence in SkyWest’s outlook. These moves, along with high marks in value, growth, and momentum, are fueling questions for investors about what comes next for SkyWest’s share price. Looking back, the past year has been quite impressive...

If you’re keeping an eye on IDEXX Laboratories (IDXX), this week’s move might give you pause for thought. The company has raised its annual revenue outlook, thanks to steady growth in both its pet healthcare segment and its water testing operations. This kind of upbeat guidance is usually welcomed by investors, as it signals confidence from management and hints at real business traction underneath the headlines. The timing of IDEXX’s guidance update aligns with a broader period of momentum...

Trying to figure out whether to buy, hold, or walk away from Blackstone stock right now? You are not alone. There are plenty of good reasons why investors are watching this name so closely. The stock has delivered a whirlwind of returns over the past few years, with a stunning 283.8% rise in five years and a 24.9% jump in the last twelve months. Even if you zoom in a bit, Blackstone still looks compelling by historical standards. Short-term investors saw the stock dip 0.8% over the last week...

Silgan Holdings has recently completed a €600 million offering of 4.25% senior unsecured notes due February 2031, with proceeds aimed at repaying revolving loans under its senior secured credit facility and funding other general corporate purposes. This move signals an active approach to managing the company’s capital structure, with potential implications for Silgan’s financial flexibility and future cost of capital. We'll examine how Silgan's substantial debt refinancing initiative may...

BrightSpring Health Services recently delivered a strong quarter, exceeding analyst expectations for both revenue and earnings and raising its full-year EBITDA guidance. This performance comes as the senior health, home health, and hospice industries face demographic-driven growth but contend with persistent labor shortages and reimbursement uncertainties. We'll explore how BrightSpring Health Services' upgraded EBITDA outlook could influence its investment narrative and long-term growth...

At Citi's 2025 Global TMT Conference, Amplitude's CFO outlined new initiatives focused on integrating AI capabilities into the platform and improving financial efficiency by reducing sales and marketing expenses to the mid-30% range of revenue. These developments highlight Amplitude’s effort to strengthen its margins while leveraging AI and recent acquisitions to enhance its position as a comprehensive digital analytics provider. We'll explore how the company's commitment to margins and AI...

Boston Scientific recently announced that Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions, retired from his role effective December 1, 2025, and will remain as a senior advisor until February 27, 2026. This transition represents a significant leadership change in a major business unit and may impact the company’s ongoing strategic initiatives. With this executive transition now underway, we’ll explore how leadership succession in the Peripheral...

Stride (LRN) just grabbed investors' attention after a standout fourth quarter, where management delivered far more than what Wall Street expected. The company exceeded earnings projections and then raised its forward guidance for the next year. Add in an eye-catching 20% surge in total enrollments, particularly the 33% jump in its Career Learning segment, and it is clear why Stride is making waves as digital education gains momentum, AI becomes integral to learning, and remote schooling...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Trying to decide what to do with DENTSPLY SIRONA (XRAY) after the latest headlines? The company just revealed a $214 million noncash impairment hit, mostly attributed to tariffs and weaker sales in its U.S. tech, orthodontic, and implant divisions. Management has highlighted ongoing margin and earnings pressure from these tariff-related costs, but they are emphasizing a new CEO-driven strategy focused on placing customers at the center and accelerating innovation to address these challenges...

In the past week, UMB Financial Corporation announced the redemption of its 3.70% Fixed-to-Fixed Rate Subordinated Notes due 2030, alongside recent insider transactions by directors and executive management. This combination of debt restructuring and insider moves provides insight into the company's evolving capital strategy and leadership's confidence in future prospects. We will explore how the note redemption may shape UMB Financial's investment narrative in the context of its ongoing...

In the past week, Merck and Daiichi Sankyo reported that ifinatamab deruxtecan showed clinically meaningful response rates in previously treated extensive-stage small cell lung cancer, and Merck announced positive Phase 3 results for enlicitide decanoate in hypercholesterolemia. The advancements reflect Merck's ongoing focus on addressing high unmet needs across both oncology and cardiovascular disease, with recent regulatory designations and late-stage clinical progress supporting its...

If you are watching Kenvue (KVUE), you have probably noticed the headlines swirling around Tylenol and a potential link to autism after a forthcoming statement from the Health Secretary. News that the report could suggest a connection between prenatal Tylenol use and autism sent shares lower, raising the stakes for the company’s reputation and future sales. Kenvue, for its part, has firmly reiterated that major regulators and leading medical organizations stand by the drug’s safety. This is...

If you are holding shares of Zimmer Biomet Holdings (ZBH), last week's news about the company issuing CHF 600 million in new senior unsecured bonds may have caught your eye. Adding this mix of Swiss franc-denominated debt gives Zimmer Biomet more room to maneuver, with proceeds that boost corporate liquidity and signal ongoing balance sheet management. Especially in today’s market, these terms such as annual interest, flexible redemption, and added bondholder protections suggest that Zimmer...

Build-A-Bear Workshop (BBW) has caught the market’s eye after delivering a series of upbeat announcements. The company reported strong second quarter results, showing a clear lift in revenue and net income from the previous year. Alongside the financial update, management raised its guidance for both earnings and new store locations for 2025, signaling a dose of confidence about the business’s future path. This mix of strong earnings, upgraded guidance, and an accelerating expansion plan has...

If you’re weighing your next move with HCA Healthcare (HCA), the latest legal twist probably caught your eye. A Tennessee federal judge just rejected HCA Healthcare’s effort to pause the evidence-gathering phase in a lawsuit over alleged misuse of forfeited employee 401(k) funds. While this might sound like just another lawsuit, it directly puts the company’s employee benefits practices in the spotlight and introduces near-term risks that investors cannot ignore. Zooming out, this legal...

If you have been eyeing Asana (ASAN) recently, this might be one of those moments that stop you in your tracks. The company just released its second-quarter results, reporting sales growth and narrower losses, and even gave upbeat guidance for the year ahead. Yet, almost immediately, shares tumbled more than 8% as investors zeroed in on operational weaknesses and lingering questions about profitability. Combined with a weak U.S. jobs report fueling broader selling pressure, this has created...

AST SpaceMobile (ASTS) is making waves again, capturing the attention of investors after announcing two major operational milestones. Just this week, the company revealed that its first Block 2 BlueBird satellite, BlueBird 6, is fully assembled and undergoing final testing before shipment. Even more impressive, AST SpaceMobile has secured Federal Communications Commission approval to launch 20 satellites, clearing regulatory hurdles that many in the industry stumble over. These achievements...